IgG4-related Disease Clinical Trial
Official title:
Infraorbital Nerve Involvement on Magnetic Resonance Imaging in European Patients With IgG4-related Ophthalmic Disease
Infraorbital nerve enlargement (IONE) on magnetic resonance imaging is known to be a possible consequence of IgG4-related ophthalmic disease. However this imaging sign can also be found in other conditions causing orbital inflammation. This study aims at comparing the frequency of IONE in patients suffering from IgG4-related ophthalmic disease (IgG4-ROD) versus patients suffering from non-IgG4-related ophthalmic disease (non-IgG4-ROD)
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03368274 -
To Evaluate the Clinical Efficacy of Iguratimod in the Treatment of IgG4 Related Disease (IgG4-RD) With Mild Symptom
|
Phase 4 | |
Not yet recruiting |
NCT03267875 -
A Laboratory Scan of Patients With Aortic Aneurysms to IgG4 Levels in the Blood
|
N/A | |
Completed |
NCT02616705 -
Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis
|
||
Completed |
NCT03669861 -
Safety and Efficacy of Abatacept in IgG4-Related Disease
|
Phase 2 | |
Recruiting |
NCT05625581 -
Tofatib Treatment for IgG4-related Disease
|
||
Recruiting |
NCT04125511 -
Characterizing IgG4-RD With 68Ga-FAPI PET/CT
|
Early Phase 1 | |
Not yet recruiting |
NCT06285539 -
Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases
|
Phase 2 | |
Not yet recruiting |
NCT05746689 -
Study of Sirolimus in IgG4-related Disease
|
N/A | |
Completed |
NCT02899039 -
Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease
|
N/A | |
Recruiting |
NCT04660565 -
Belimumab Treatment for IgG4-related Disease
|
Phase 4 | |
Recruiting |
NCT01670695 -
A Prospective Cohort Study of IgG4RD in China
|
N/A | |
Recruiting |
NCT03023371 -
National Registry of IgG4-RD in China
|
N/A | |
Unknown status |
NCT01758393 -
Glucocorticoids in Patients With IgG4-RD
|
Phase 2/Phase 3 | |
Completed |
NCT02705638 -
Treatment of IgG4-Related Disease With Revlimid and Rituximab
|
Phase 1 | |
Recruiting |
NCT03473912 -
Meir Medical Center Rheumatologic Biobank
|
||
Not yet recruiting |
NCT03466970 -
Plasmablast Detection From IgG4-Related Disease Patients
|
N/A |